113 related articles for article (PubMed ID: 19029817)
1. Skp2 and salivary cancer.
Ben-Izhak O; Akrish S; Gan S; Nagler RM
Cancer Biol Ther; 2009 Jan; 8(2):153-8. PubMed ID: 19029817
[TBL] [Abstract][Full Text] [Related]
2. Ki67 and salivary cancer.
Ben-Izhak O; Akrish S; Nagler RM
Cancer Invest; 2008 Dec; 26(10):1015-23. PubMed ID: 19093259
[TBL] [Abstract][Full Text] [Related]
3. p27 and salivary cancer.
Ben-Izhak O; Akrish S; Gan S; Nagler RM
Cancer Immunol Immunother; 2009 Mar; 58(3):469-73. PubMed ID: 18663445
[TBL] [Abstract][Full Text] [Related]
4. The salivary tip of the p53 mutagenesis iceberg: novel insights.
Ben-Izhak O; Laster Z; Akrish S; Muska E; Gan S; Nagler RM
Cancer Biomark; 2009; 5(1):23-31. PubMed ID: 19242059
[TBL] [Abstract][Full Text] [Related]
5. Skp2 expression is associated with down-regulation of p27 protein and cell proliferation in salivary adenoid cystic carcinoma.
Keikhaee MR; Kudo Y; Siriwardena S; Wu L; Ogawa I; Takata T
Virchows Arch; 2007 May; 450(5):567-74. PubMed ID: 17431674
[TBL] [Abstract][Full Text] [Related]
6. The expression and prognostic significance of Cks1 in salivary cancer.
Nagler RM; Ben-Izhak O; Ostrovsky D; Golz A; Hershko DD
Cancer Invest; 2009 Jun; 27(5):512-20. PubMed ID: 19296297
[TBL] [Abstract][Full Text] [Related]
7. Prognostic role of apoptotic, Bcl-2, c-erbB-2 and p53 tumor markers in salivary gland malignancies.
Nagler RM; Kerner H; Ben-Eliezer S; Minkov I; Ben-Itzhak O
Oncology; 2003; 64(4):389-98. PubMed ID: 12759537
[TBL] [Abstract][Full Text] [Related]
8. TUNEL - an efficient prognosis predictor of salivary malignancies.
Ben-Izhak O; Laster Z; Araidy S; Nagler RM
Br J Cancer; 2007 Apr; 96(7):1101-6. PubMed ID: 17325701
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of S-phase kinase-associated protein 2 and p27kip1 in patients with diffuse large B-cell lymphoma: effects of rituximab.
Seki R; Ohshima K; Fujisaki T; Uike N; Kawano F; Gondo H; Makino S; Eto T; Moriuchi Y; Taguchi F; Kamimura T; Tsuda H; Shimoda K; Okamura T
Ann Oncol; 2010 Apr; 21(4):833-841. PubMed ID: 19889619
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the expression of the cell cycle regulatory protein cyclin kinase subunit 1 in colorectal carcinoma.
Shapira M; Ben-Izhak O; Bishara B; Futerman B; Minkov I; Krausz MM; Pagano M; Hershko DD
Cancer; 2004 Apr; 100(8):1615-21. PubMed ID: 15073847
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.
Liu J; Wei XL; Huang WH; Chen CF; Bai JW; Zhang GJ
PLoS One; 2012; 7(12):e52675. PubMed ID: 23300741
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of Skp2 expression, alone and combined with Jab1 and p27 in epithelial ovarian tumors.
Sui L; Dong Y; Watanabe Y; Yamaguchi F; Sugimoto K; Tokuda M
Oncol Rep; 2006 Apr; 15(4):765-71. PubMed ID: 16525656
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemically detected expression of p27(Kip1) and Skp2 predicts survival in patients with intrahepatic cholangiocarcinomas.
Hashimoto N; Yachida S; Okano K; Wakabayashi H; Imaida K; Kurokohchi K; Masaki T; Kinoshita H; Tominaga M; Ajiki T; Ku Y; Okabayashi T; Hanazaki K; Hiroi M; Izumi S; Mano S; Okada S; Karasawa Y; Maeba T; Suzuki Y
Ann Surg Oncol; 2009 Feb; 16(2):395-403. PubMed ID: 19034576
[TBL] [Abstract][Full Text] [Related]
14. Skp2 overexpression is highly representative of intrinsic biological aggressiveness and independently associated with poor prognosis in primary localized myxofibrosarcomas.
Huang HY; Kang HY; Li CF; Eng HL; Chou SC; Lin CN; Hsiung CY
Clin Cancer Res; 2006 Jan; 12(2):487-98. PubMed ID: 16428491
[TBL] [Abstract][Full Text] [Related]
15. Significance of skp2 expression in primary breast cancer.
Sonoda H; Inoue H; Ogawa K; Utsunomiya T; Masuda TA; Mori M
Clin Cancer Res; 2006 Feb; 12(4):1215-20. PubMed ID: 16489076
[TBL] [Abstract][Full Text] [Related]
16. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
17. Oropharyngeal cancer pathogenesis: ubiquitin proteolytic, apoptotic and epidermal growth factor related pathways act in concert--first report.
Ben-Izhak O; Kablan F; Laster Z; Nagler RM
Oral Oncol; 2005 Sep; 41(8):851-60. PubMed ID: 16043384
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of Skp2 and p27 in human breast cancer.
Traub F; Mengel M; Lück HJ; Kreipe HH; von Wasielewski R
Breast Cancer Res Treat; 2006 Sep; 99(2):185-91. PubMed ID: 16636894
[TBL] [Abstract][Full Text] [Related]
19. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
[TBL] [Abstract][Full Text] [Related]
20. The prognostic role of Skp2 and the tumor suppressor protein p27 in colorectal cancer.
Vasile Bochis O; Achimas-Cadariu P; Vlad C; Fetica B; Corneliu Leucuta D; Ioan Busuioc C; Irimie A
J BUON; 2017; 22(5):1122-1130. PubMed ID: 29135092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
